Characteristics of the HumanMethylation450k datasets in DoSurvive.


Number of Patients tested with HumanMethylation450k array.

Cancer Types Patients (OS) Patients (DSS) Patients (DFI) Patients (PFI) Gene (OS)
Adrenocortical carcinoma (ACC) 80 78 45 80 368715
Bladder Urothelial Carcinoma (BLCA) 411 397 189 412 370147
Breast invasive carcinoma (BRCA) 789 777 689 789 369127
Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) 307 303 176 307 370854
Cholangiocarcinoma (CHOL) 36 35 24 36 371969
Colon adenocarcinoma (COAD) 293 277 111 293 372785
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (DLBC) 48 48 28 48 372966
Esophageal carcinoma (ESCA) 185 183 89 185 370770
Glioblastoma multiforme (GBM) 139 131 3 139 367418
Head and Neck squamous cell carcinoma (HNSC) 527 501 133 527 371915
Kidney Chromophobe (KICH) 65 65 29 65 368526
Kidney renal clear cell carcinoma (KIRC) 319 310 97 318 361376
Kidney renal papillary cell carcinoma (KIRP) 274 270 177 273 366424
Acute Myeloid Leukemia (LAML) 180 0 0 0 362706
Brain Lower Grade Glioma (LGG) 514 506 133 514 371428
Liver hepatocellular carcinoma (LIHC) 376 367 322 376 372442
Lung adenocarcinoma (LUAD) 452 424 278 452 388935
Lung squamous cell carcinoma (LUSC) 366 323 250 367 369304
Mesothelioma (MESO) 86 66 15 84 374628
Ovarian serous cystadenocarcinoma (OV) 10 10 7 10 367417
Pancreatic adenocarcinoma (PAAD) 184 177 69 184 371636
Pheochromocytoma and Paraganglioma (PCPG) 179 179 160 179 369591
Prostate adenocarcinoma (PRAD) 498 496 338 498 368423
Rectum adenocarcinoma (READ) 97 91 30 97 365522
Sarcoma (SARC) 261 255 153 261 365555
Skin Cutaneous Melanoma (SKCM) 455 449 0 456 369180
Stomach adenocarcinoma (STAD) 390 381 253 392 371934
Testicular Germ Cell Tumors (TGCT) 134 134 105 134 368244
Thyroid carcinoma (THCA) 503 497 354 503 367686
Thymoma (THYM) 123 123 0 123 367834
Uterine Corpus Endometrial Carcinoma (UCEC) 431 429 323 431 372228
Uterine Carcinosarcoma (UCS) 57 55 27 57 370751
Uveal Melanoma (UVM) 80 80 0 79 363720
*OS: Overall survival, DSS: Disease-specific survival, DFI: Disease-free survival, PFI: Progression-free survival